Sienna Biopharmaceuticals (SNNA) Prices 4.33M Share IPO at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Sienna Biopharmaceuticals (SNNA) IPO Opens Sharply Higher
July 27, 2017 10:33 AM EDTToday's IPO for Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) opened for trading at $19.05 after pricing 4,333,333 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts.
J.P. Morgan and Cowen are acting as joint book-running managers for the... More
